Premium
THE BRUTON'S TYROSINE KINASE INHIBITOR IBRUTINIB EXERTS IMMUNOMODULATORY ACTIVITY TOWARDS TUMOR‐INFILTRATING MACROPHAGES
Author(s) -
Ding N.,
Ping L.,
Shi Y.,
Feng L.,
Li J.,
Liu Y.,
Lin Y.,
Shi C.,
Wang X.,
Pan Z.,
Song Y.,
Zhu J.
Publication year - 2017
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.2439_177
Subject(s) - bruton's tyrosine kinase , ibrutinib , chemokine , cancer research , tumor microenvironment , proinflammatory cytokine , tyrosine kinase , immunology , biology , signal transduction , microbiology and biotechnology , immune system , inflammation , chronic lymphocytic leukemia , leukemia , tumor cells